Lung Cancer Attributed Mortality Among 316,336 Early Stage Breast Cancer Cases Treated by Radiotherapy and/or Chemotherapy, 2000–2015: Evidence From the SEER Database
To estimate the risk of death from lung cancer in patients treated for breast cancer (BC) in relation to the general population. BC data, covering 2000 to 2015, were extracted from the Surveillance, Epidemiology and End Results-18 (SEER-18) cancer registry database. A comparison of lung cancer attri...
Uloženo v:
| Vydáno v: | Frontiers in oncology Ročník 10; s. 602397 |
|---|---|
| Hlavní autoři: | , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
Switzerland
Frontiers Media S.A
25.02.2021
|
| Témata: | |
| ISSN: | 2234-943X, 2234-943X |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | To estimate the risk of death from lung cancer in patients treated for breast cancer (BC) in relation to the general population.
BC data, covering 2000 to 2015, were extracted from the Surveillance, Epidemiology and End Results-18 (SEER-18) cancer registry database. A comparison of lung cancer attributed mortality between BC patients and the general population was performed using standardized mortality ratios (SMRs) and SMRs conditional on survival length (cSMRs). Prognostic factors of lung cancer mortality were identified using flexible parametric modelling. Our model adjusts the effect of downstream (histopathological BC tumor grade and hormone receptor status) and upstream (age at diagnosis, ethnicity, and marital status) factors.
The median follow-up was 6.4 years (interquartile range, 3.0-10.3 years). BC cases who received only radiotherapy (cSMR = 0.93; 95%CI: 0.77-1.13), only chemotherapy (cSMR = 0.91; 0.62-1.33), and radio-and chemotherapy (cSMR = 1.04; 0.77-1.39) had no evidence of increased lung cancer mortality relative to the general population. The adjusted model identified that lung cancer mortality was higher for women who were older at diagnosis compared to those <50 years (ranging from HR50-59 = 3.41 [95%CI: 2.72-4.28] to HR70-79 = 10.53 [95%CI: 8.44-13.13]) and for cases with negative estrogen and progesterone receptors (HR =1.38; 95% CI: 1.21-1.57). Compared to married cases, widowed, divorced, single or others had a 76%, 45%, and 25% higher hazard of lung cancer mortality, respectively. Lung cancer mortality was lower for American Indian/Alaska Native and Asian/Pacific Islander ethnicities (HR = 0.51; 95% CI: 0.40-0.64) compared to BC cases with white ethnic background.
There is no evidence for a higher lung cancer mortality in BC patients when compared to the general population. |
|---|---|
| AbstractList | To estimate the risk of death from lung cancer in patients treated for breast cancer (BC) in relation to the general population.
BC data, covering 2000 to 2015, were extracted from the Surveillance, Epidemiology and End Results-18 (SEER-18) cancer registry database. A comparison of lung cancer attributed mortality between BC patients and the general population was performed using standardized mortality ratios (SMRs) and SMRs conditional on survival length (cSMRs). Prognostic factors of lung cancer mortality were identified using flexible parametric modelling. Our model adjusts the effect of downstream (histopathological BC tumor grade and hormone receptor status) and upstream (age at diagnosis, ethnicity, and marital status) factors.
The median follow-up was 6.4 years (interquartile range, 3.0-10.3 years). BC cases who received only radiotherapy (cSMR = 0.93; 95%CI: 0.77-1.13), only chemotherapy (cSMR = 0.91; 0.62-1.33), and radio-and chemotherapy (cSMR = 1.04; 0.77-1.39) had no evidence of increased lung cancer mortality relative to the general population. The adjusted model identified that lung cancer mortality was higher for women who were older at diagnosis compared to those <50 years (ranging from HR50-59 = 3.41 [95%CI: 2.72-4.28] to HR70-79 = 10.53 [95%CI: 8.44-13.13]) and for cases with negative estrogen and progesterone receptors (HR =1.38; 95% CI: 1.21-1.57). Compared to married cases, widowed, divorced, single or others had a 76%, 45%, and 25% higher hazard of lung cancer mortality, respectively. Lung cancer mortality was lower for American Indian/Alaska Native and Asian/Pacific Islander ethnicities (HR = 0.51; 95% CI: 0.40-0.64) compared to BC cases with white ethnic background.
There is no evidence for a higher lung cancer mortality in BC patients when compared to the general population. To estimate the risk of death from lung cancer in patients treated for breast cancer (BC) in relation to the general population.OBJECTIVETo estimate the risk of death from lung cancer in patients treated for breast cancer (BC) in relation to the general population.BC data, covering 2000 to 2015, were extracted from the Surveillance, Epidemiology and End Results-18 (SEER-18) cancer registry database. A comparison of lung cancer attributed mortality between BC patients and the general population was performed using standardized mortality ratios (SMRs) and SMRs conditional on survival length (cSMRs). Prognostic factors of lung cancer mortality were identified using flexible parametric modelling. Our model adjusts the effect of downstream (histopathological BC tumor grade and hormone receptor status) and upstream (age at diagnosis, ethnicity, and marital status) factors.METHODSBC data, covering 2000 to 2015, were extracted from the Surveillance, Epidemiology and End Results-18 (SEER-18) cancer registry database. A comparison of lung cancer attributed mortality between BC patients and the general population was performed using standardized mortality ratios (SMRs) and SMRs conditional on survival length (cSMRs). Prognostic factors of lung cancer mortality were identified using flexible parametric modelling. Our model adjusts the effect of downstream (histopathological BC tumor grade and hormone receptor status) and upstream (age at diagnosis, ethnicity, and marital status) factors.The median follow-up was 6.4 years (interquartile range, 3.0-10.3 years). BC cases who received only radiotherapy (cSMR = 0.93; 95%CI: 0.77-1.13), only chemotherapy (cSMR = 0.91; 0.62-1.33), and radio-and chemotherapy (cSMR = 1.04; 0.77-1.39) had no evidence of increased lung cancer mortality relative to the general population. The adjusted model identified that lung cancer mortality was higher for women who were older at diagnosis compared to those <50 years (ranging from HR50-59 = 3.41 [95%CI: 2.72-4.28] to HR70-79 = 10.53 [95%CI: 8.44-13.13]) and for cases with negative estrogen and progesterone receptors (HR =1.38; 95% CI: 1.21-1.57). Compared to married cases, widowed, divorced, single or others had a 76%, 45%, and 25% higher hazard of lung cancer mortality, respectively. Lung cancer mortality was lower for American Indian/Alaska Native and Asian/Pacific Islander ethnicities (HR = 0.51; 95% CI: 0.40-0.64) compared to BC cases with white ethnic background.RESULTSThe median follow-up was 6.4 years (interquartile range, 3.0-10.3 years). BC cases who received only radiotherapy (cSMR = 0.93; 95%CI: 0.77-1.13), only chemotherapy (cSMR = 0.91; 0.62-1.33), and radio-and chemotherapy (cSMR = 1.04; 0.77-1.39) had no evidence of increased lung cancer mortality relative to the general population. The adjusted model identified that lung cancer mortality was higher for women who were older at diagnosis compared to those <50 years (ranging from HR50-59 = 3.41 [95%CI: 2.72-4.28] to HR70-79 = 10.53 [95%CI: 8.44-13.13]) and for cases with negative estrogen and progesterone receptors (HR =1.38; 95% CI: 1.21-1.57). Compared to married cases, widowed, divorced, single or others had a 76%, 45%, and 25% higher hazard of lung cancer mortality, respectively. Lung cancer mortality was lower for American Indian/Alaska Native and Asian/Pacific Islander ethnicities (HR = 0.51; 95% CI: 0.40-0.64) compared to BC cases with white ethnic background.There is no evidence for a higher lung cancer mortality in BC patients when compared to the general population.CONCLUSIONSThere is no evidence for a higher lung cancer mortality in BC patients when compared to the general population. ObjectiveTo estimate the risk of death from lung cancer in patients treated for breast cancer (BC) in relation to the general population.MethodsBC data, covering 2000 to 2015, were extracted from the Surveillance, Epidemiology and End Results-18 (SEER-18) cancer registry database. A comparison of lung cancer attributed mortality between BC patients and the general population was performed using standardized mortality ratios (SMRs) and SMRs conditional on survival length (cSMRs). Prognostic factors of lung cancer mortality were identified using flexible parametric modelling. Our model adjusts the effect of downstream (histopathological BC tumor grade and hormone receptor status) and upstream (age at diagnosis, ethnicity, and marital status) factors.ResultsThe median follow-up was 6.4 years (interquartile range, 3.0–10.3 years). BC cases who received only radiotherapy (cSMR = 0.93; 95%CI: 0.77–1.13), only chemotherapy (cSMR = 0.91; 0.62–1.33), and radio-and chemotherapy (cSMR = 1.04; 0.77–1.39) had no evidence of increased lung cancer mortality relative to the general population. The adjusted model identified that lung cancer mortality was higher for women who were older at diagnosis compared to those <50 years (ranging from HR50-59 = 3.41 [95%CI: 2.72–4.28] to HR70-79 = 10.53 [95%CI: 8.44–13.13]) and for cases with negative estrogen and progesterone receptors (HR =1.38; 95% CI: 1.21–1.57). Compared to married cases, widowed, divorced, single or others had a 76%, 45%, and 25% higher hazard of lung cancer mortality, respectively. Lung cancer mortality was lower for American Indian/Alaska Native and Asian/Pacific Islander ethnicities (HR = 0.51; 95% CI: 0.40–0.64) compared to BC cases with white ethnic background.ConclusionsThere is no evidence for a higher lung cancer mortality in BC patients when compared to the general population. |
| Author | Abera, Semaw Ferede Glowka, André Medenwald, Daniel Bedir, Ahmed Mikolajczyk, Rafael T. Vordermark, Dirk Ostheimer, Christian Kantelhardt, Eva Johanna Efremov, Ljupcho |
| AuthorAffiliation | 1 Department of Radiation Oncology, Faculty of Medicine, Martin-Luther-University Halle-Wittenberg , Halle (Saale) , Germany 2 Institute for Medical Epidemiology, Biometrics and Informatics (IMEBI), Interdisciplinary Center for Health Sciences, Medical School of the Martin-Luther-University Halle-Wittenberg , Halle (Saale) , Germany 3 Department of Gynaecology, Faculty of Medicine, Martin-Luther-University Halle-Wittenberg , Halle (Saale) , Germany |
| AuthorAffiliation_xml | – name: 2 Institute for Medical Epidemiology, Biometrics and Informatics (IMEBI), Interdisciplinary Center for Health Sciences, Medical School of the Martin-Luther-University Halle-Wittenberg , Halle (Saale) , Germany – name: 1 Department of Radiation Oncology, Faculty of Medicine, Martin-Luther-University Halle-Wittenberg , Halle (Saale) , Germany – name: 3 Department of Gynaecology, Faculty of Medicine, Martin-Luther-University Halle-Wittenberg , Halle (Saale) , Germany |
| Author_xml | – sequence: 1 givenname: Semaw Ferede surname: Abera fullname: Abera, Semaw Ferede – sequence: 2 givenname: Rafael T. surname: Mikolajczyk fullname: Mikolajczyk, Rafael T. – sequence: 3 givenname: Eva Johanna surname: Kantelhardt fullname: Kantelhardt, Eva Johanna – sequence: 4 givenname: Ljupcho surname: Efremov fullname: Efremov, Ljupcho – sequence: 5 givenname: Ahmed surname: Bedir fullname: Bedir, Ahmed – sequence: 6 givenname: Christian surname: Ostheimer fullname: Ostheimer, Christian – sequence: 7 givenname: André surname: Glowka fullname: Glowka, André – sequence: 8 givenname: Dirk surname: Vordermark fullname: Vordermark, Dirk – sequence: 9 givenname: Daniel surname: Medenwald fullname: Medenwald, Daniel |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33718108$$D View this record in MEDLINE/PubMed |
| BookMark | eNp1ks1uEzEUhUeoiJbSPSvkJYsm9d_YMyyQQkihUhBSWyR2lse-k7qaGQfbqZQd78BL8Fw8CR7SoBYJb2xdn_MdSz7Pi4PBD1AULwmeMlbVZ60fzJRiiqcCU1bLJ8URpYxPas6-Hjw4HxYnMd7ivESJCWbPikPGJKkIro6Kn8vNsEJzPRgIaJZScM0mgUWffEi6c2mLZr3PCkbEKWMCLXTotugq6RWgdwF0THvzXEeI6DrPRn-zRZfaOp9uIOj1FunBnvksuoF-PztFNL_p1_cfFJPyDVrcOQuZhM6D71HWoKvF4hK910k3Gf2ieNrqLsLJ_X5cfDlfXM8_TpafP1zMZ8uJ4YKmiYCqbXFFAZita06IabUtG9wKC1jYVpS2rHHTSCO5oQZo1RBZ6pLSpoZWUHZcXOy41utbtQ6u12GrvHbqz8CHldIhOdOBMjWnIKXRopKc2KrmpaWiFpw3gLEUmfV2x1pvmh6sgSEF3T2CPr4Z3I1a-Tslay4pwxnw-h4Q_LcNxKR6Fw10nR7Ab6Ki-UO5lJKOWa8eZv0N2X91FoidwAQfY4BWGZd0cn6Mdp0iWI21UmOt1FgrtatVNuJ_jHv2fy2_AWBm0Ck |
| CitedBy_id | crossref_primary_10_1177_23247096241272013 |
| Cites_doi | 10.1136/bmj.e2718 10.1007/s12013-014-0459-6 10.1038/sj.clpt.6100449 10.1093/jnci/djr188 10.3389/fonc.2018.00427 10.1097/PAS.0000000000000749 10.1016/S1470-2045(05)70251-5 10.1245/s10434-010-0985-4 10.1007/s10552-008-9261-3 10.1002/cncr.26295 10.1136/jamia.1994.95236162 10.1016/j.meddos.2018.03.002 10.5306/wjco.v5.i3.283 10.1097/MLR.0000000000000073 10.1097/MD.0000000000012603 10.1016/j.radonc.2016.08.017 10.1016/S1470-2045(10)70056-5 10.1002/sim.7501 10.3322/caac.21565 10.1158/1078-0432.CCR-06-1210 10.1002/sim.4384 10.1016/j.breast.2016.12.008 10.3322/caac.21348 10.1002/sim.7498 10.1200/JCO.2017.73.7932 10.1200/JCO.2013.49.6489 10.3322/caac.21349 10.3892/ol.2013.1566 10.1038/bjc.2012.575 10.1634/theoncologist.2011-0169 10.1016/S0140-6736(10)62231-3 10.1200/JCO.2016.72.0722 10.7314/APJCP.2016.17.S3.43 10.1016/S1470-2045(05)70258-8 10.1016/j.critrevonc.2009.08.002 10.1080/01621459.1999.10474144 10.3322/caac.21551 10.1007/s10552-012-0054-3 10.1016/j.clnu.2013.05.014 10.1371/journal.pone.0175515 |
| ContentType | Journal Article |
| Copyright | Copyright © 2021 Abera, Mikolajczyk, Kantelhardt, Efremov, Bedir, Ostheimer, Glowka, Vordermark and Medenwald. Copyright © 2021 Abera, Mikolajczyk, Kantelhardt, Efremov, Bedir, Ostheimer, Glowka, Vordermark and Medenwald 2021 Abera, Mikolajczyk, Kantelhardt, Efremov, Bedir, Ostheimer, Glowka, Vordermark and Medenwald |
| Copyright_xml | – notice: Copyright © 2021 Abera, Mikolajczyk, Kantelhardt, Efremov, Bedir, Ostheimer, Glowka, Vordermark and Medenwald. – notice: Copyright © 2021 Abera, Mikolajczyk, Kantelhardt, Efremov, Bedir, Ostheimer, Glowka, Vordermark and Medenwald 2021 Abera, Mikolajczyk, Kantelhardt, Efremov, Bedir, Ostheimer, Glowka, Vordermark and Medenwald |
| DBID | AAYXX CITATION NPM 7X8 5PM DOA |
| DOI | 10.3389/fonc.2020.602397 |
| DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitleList | PubMed MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 2234-943X |
| ExternalDocumentID | oai_doaj_org_article_c942e77ca68741d8945d269644be0076 PMC7947230 33718108 10_3389_fonc_2020_602397 |
| Genre | Journal Article |
| GroupedDBID | 53G 5VS 9T4 AAFWJ AAKDD AAYXX ACGFO ACGFS ADBBV ADRAZ AFPKN ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV CITATION DIK EBS EJD EMOBN GROUPED_DOAJ GX1 HYE KQ8 M48 M~E OK1 PGMZT RNS RPM ACXDI IPNFZ NPM RIG 7X8 5PM |
| ID | FETCH-LOGICAL-c462t-6e8ff082ee3d99411cfad5b0f6de06df65d590bb7c74c2ce28b175a522b9ef623 |
| IEDL.DBID | DOA |
| ISICitedReferencesCount | 1 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000627337900001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 2234-943X |
| IngestDate | Fri Oct 03 12:53:43 EDT 2025 Thu Aug 21 18:42:48 EDT 2025 Thu Oct 02 12:00:07 EDT 2025 Mon Jul 21 05:18:05 EDT 2025 Sat Nov 29 06:47:24 EST 2025 Tue Nov 18 22:15:20 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | lung cancer radiotherapy breast cancer risk general population chemotherapy |
| Language | English |
| License | Copyright © 2021 Abera, Mikolajczyk, Kantelhardt, Efremov, Bedir, Ostheimer, Glowka, Vordermark and Medenwald. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c462t-6e8ff082ee3d99411cfad5b0f6de06df65d590bb7c74c2ce28b175a522b9ef623 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 This article was submitted to Radiation Oncology, a section of the journal Frontiers in Oncology Edited by: Drexell Hunter Boggs, University of Alabama at Birmingham, United States Reviewed by: John Michael Stahl, University of Alabama at Birmingham, United States; Yee Ung, Sunnybrook Health Sciences Centre, Canada |
| OpenAccessLink | https://doaj.org/article/c942e77ca68741d8945d269644be0076 |
| PMID | 33718108 |
| PQID | 2501477726 |
| PQPubID | 23479 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_c942e77ca68741d8945d269644be0076 pubmedcentral_primary_oai_pubmedcentral_nih_gov_7947230 proquest_miscellaneous_2501477726 pubmed_primary_33718108 crossref_citationtrail_10_3389_fonc_2020_602397 crossref_primary_10_3389_fonc_2020_602397 |
| PublicationCentury | 2000 |
| PublicationDate | 2021-02-25 |
| PublicationDateYYYYMMDD | 2021-02-25 |
| PublicationDate_xml | – month: 02 year: 2021 text: 2021-02-25 day: 25 |
| PublicationDecade | 2020 |
| PublicationPlace | Switzerland |
| PublicationPlace_xml | – name: Switzerland |
| PublicationTitle | Frontiers in oncology |
| PublicationTitleAlternate | Front Oncol |
| PublicationYear | 2021 |
| Publisher | Frontiers Media S.A |
| Publisher_xml | – name: Frontiers Media S.A |
| References | Miller (B3) 2019; 69 Tao (B5) 2015; 72 Taylor (B15) 2017; 35 Jemal (B23) 2018; 36 Mozumder (B29) 2018; 37 (B20) 2016 Edge (B22) 2010; 17 Friede (B21) 1994; 1 Kesson (B7) 2012; 344 Hinyard (B39) 2017; 32 Lorigan (B13) 2010; 11 Peppone (B33) 2011; 16 Noone (B42) 2016; 54 (B2) 2017 Byers (B8) 2016; 66 Grantzau (B17) 2016; 121 Gironés (B37) 2010; 73 Koller (B26) 2012; 31 Wang (B34) 2018; 8 Fine (B28) 1999; 94 Siegel (B4) 2019; 69 Moulder (B9) 2008; 83 Aizer (B40) 2013; 31 Goldoni (B30) 2009; 20 Kim (B25) 2007; 13 Martínez (B41) 2017; 12 Ghoncheh (B1) 2016; 17 Darby (B14) 2005; 6 Coleman (B11) 2011; 377 Patnaik (B38) 2011; 103 Tas (B24) 2013; 6 Henson (B16) 2013; 108 Saw (B31) 2018; 43 Shah (B6) 2014; 5 Liu (B12) 2018; 97 Duggan (B18) 2016; 40 Schonfeld (B35) 2012; 23 (B19) 2010 Austin (B27) 2017; 36 Paillaud (B36) 2014; 33 Orecchia (B32) 2005; 6 Miller (B10) 2016; 66 Jagsi (B43) 2012; 118 |
| References_xml | – volume: 344 year: 2012 ident: B7 article-title: Effects of multidisciplinary team working on breast cancer survival: Retrospective, comparative, interventional cohort study of 13 722 women publication-title: BMJ doi: 10.1136/bmj.e2718 – volume: 72 year: 2015 ident: B5 article-title: Breast Cancer: Epidemiology and Etiology publication-title: Cell Biochem Biophys doi: 10.1007/s12013-014-0459-6 – volume: 83 start-page: 26 year: 2008 ident: B9 article-title: Advances in the treatment of breast cancer publication-title: Clin Pharmacol Ther doi: 10.1038/sj.clpt.6100449 – volume: 103 year: 2011 ident: B38 article-title: The influence of comorbidities on overall survival among older women diagnosed with breast cancer publication-title: J Natl Cancer Inst doi: 10.1093/jnci/djr188 – volume: 8 year: 2018 ident: B34 article-title: Second Primary Lung Cancer After Breast Cancer: A Population-Based Study of 6,269 Women publication-title: Front Oncol doi: 10.3389/fonc.2018.00427 – volume: 40 start-page: e94 year: 2016 ident: B18 article-title: The surveillance, epidemiology, and end results (SEER) program and pathology: Toward strengthening the critical relationship publication-title: Am J Surg Pathol doi: 10.1097/PAS.0000000000000749 – volume: 6 year: 2005 ident: B14 article-title: Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: Prospective cohort study of about 300 000 women in US SEER cancer registries publication-title: Lancet Oncol doi: 10.1016/S1470-2045(05)70251-5 – volume: 17 year: 2010 ident: B22 article-title: The american joint committee on cancer: The 7th edition of the AJCC cancer staging manual and the future of TNM publication-title: Ann Surg Oncol doi: 10.1245/s10434-010-0985-4 – volume: 20 year: 2009 ident: B30 article-title: Misclassification of breast cancer as cause of death in a service screening area publication-title: Cancer Causes Control doi: 10.1007/s10552-008-9261-3 – volume: 118 year: 2012 ident: B43 article-title: Underascertainment of radiotherapy receipt in surveillance, epidemiology, and end results registry data publication-title: Cancer doi: 10.1002/cncr.26295 – volume: 1 year: 1994 ident: B21 article-title: CDC WONDER: A cooperative processing architecture for public health publication-title: J Am Med Inf Assoc doi: 10.1136/jamia.1994.95236162 – volume: 43 year: 2018 ident: B31 article-title: 3D treatment planning systems publication-title: Med Dosim doi: 10.1016/j.meddos.2018.03.002 – volume: 5 year: 2014 ident: B6 article-title: Pathogenesis, prevention, diagnosis and treatment of breast cancer publication-title: World J Clin Oncol doi: 10.5306/wjco.v5.i3.283 – volume: 54 year: 2016 ident: B42 article-title: Comparison of SEER Treatment Data With Medicare Claims publication-title: Med Care doi: 10.1097/MLR.0000000000000073 – volume: 97 year: 2018 ident: B12 article-title: Problems to affect long-term survival for breast cancer patients An observational study of subsequent lung/bronchus malignancies publication-title: Med (United States) doi: 10.1097/MD.0000000000012603 – volume: 121 year: 2016 ident: B17 article-title: Risk of second non-breast cancer among patients treated with and without postoperative radiotherapy for primary breast cancer: A systematic review and meta-analysis of population-based studies including 522,739 patients publication-title: Radiother Oncol doi: 10.1016/j.radonc.2016.08.017 – volume: 11 year: 2010 ident: B13 article-title: Lung cancer after treatment for breast cancer publication-title: Lancet Oncol doi: 10.1016/S1470-2045(10)70056-5 – volume: 36 year: 2017 ident: B27 article-title: Practical recommendations for reporting Fine-Gray model analyses for competing risk data publication-title: Stat Med doi: 10.1002/sim.7501 – volume: 69 year: 2019 ident: B3 article-title: Cancer treatment and survivorship statistics, 2019 publication-title: CA Cancer J Clin doi: 10.3322/caac.21565 – volume-title: Wide-ranging online data for epidemiologic research (WONDER) year: 2016 ident: B20 – volume: 13 year: 2007 ident: B25 article-title: Cumulative incidence in competing risks data and competing risks regression analysis publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-06-1210 – volume: 31 year: 2012 ident: B26 article-title: Competing risks and the clinical community: Irrelevance or ignorance publication-title: Stat Med doi: 10.1002/sim.4384 – volume: 32 year: 2017 ident: B39 article-title: The effect of marital status on breast cancer-related outcomes in women under 65: A SEER database analysis publication-title: Breast doi: 10.1016/j.breast.2016.12.008 – volume: 66 year: 2016 ident: B8 article-title: The American Cancer Society challenge goal to reduce US cancer mortality by 50% between 1990 and 2015: Results and reflections publication-title: CA Cancer J Clin doi: 10.3322/caac.21348 – volume: 37 start-page: 82 year: 2018 ident: B29 article-title: Direct likelihood inference on the cause-specific cumulative incidence function: A flexible parametric regression modelling approach publication-title: Stat Med doi: 10.1002/sim.7498 – volume: 36 start-page: 14 year: 2018 ident: B23 article-title: Factors that contributed to black-white disparities in survival among nonelderly women with breast cancer between 2004 and 2013 publication-title: J Clin Oncol doi: 10.1200/JCO.2017.73.7932 – volume: 31 year: 2013 ident: B40 article-title: Marital status and survival in patients with cancer publication-title: J Clin Oncol doi: 10.1200/JCO.2013.49.6489 – volume: 66 year: 2016 ident: B10 article-title: Cancer treatment and survivorship statistics, 2016 publication-title: CA Cancer J Clin doi: 10.3322/caac.21349 – volume: 6 year: 2013 ident: B24 article-title: Age is a prognostic factor affecting survival in lung cancer patients publication-title: Oncol Lett doi: 10.3892/ol.2013.1566 – volume: 108 year: 2013 ident: B16 article-title: Radiation-related mortality from heart disease and lung cancer more than 20 years after radiotherapy for breast cancer publication-title: Br J Cancer doi: 10.1038/bjc.2012.575 – volume: 16 year: 2011 ident: B33 article-title: The Effect of Cigarette Smoking on Cancer Treatment-Related Side Effects publication-title: Oncologist doi: 10.1634/theoncologist.2011-0169 – volume: 377 year: 2011 ident: B11 article-title: Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the international cancer benchmarking partnership): An analysis of population-based cancer registry data publication-title: Lancet doi: 10.1016/S0140-6736(10)62231-3 – volume: 35 year: 2017 ident: B15 article-title: Estimating the Risks of Breast Cancer Radiotherapy: Evidence From Modern Radiation Doses to the Lungs and Heart and From Previous Randomized Trials publication-title: J Clin Oncol doi: 10.1200/JCO.2016.72.0722 – volume: 17 year: 2016 ident: B1 article-title: Incidence and Mortality and Epidemiology of Breast Cancer in the World publication-title: Asian Pac J Cancer Prev doi: 10.7314/APJCP.2016.17.S3.43 – volume: 6 year: 2005 ident: B32 article-title: Early-stage breast cancer: Risk of heart disease and lung cancer publication-title: Lancet Oncol doi: 10.1016/S1470-2045(05)70258-8 – volume-title: International Statistical Classification of Diseases and Related Health Problems (International Classification of Diseases) (ICD) 10th Revision year: 2010 ident: B19 – volume: 73 year: 2010 ident: B37 article-title: Comorbidity, disability and geriatric syndromes in elderly breast cancer survivors. Results of a single-center experience publication-title: Crit Rev Oncol Hematol doi: 10.1016/j.critrevonc.2009.08.002 – volume: 94 start-page: 496 year: 1999 ident: B28 article-title: A Proportional Hazards Model for the Subdistribution of a Competing Risk publication-title: J Am Stat Assoc doi: 10.1080/01621459.1999.10474144 – volume: 69 start-page: 7 year: 2019 ident: B4 article-title: Cancer statistics, 2019 publication-title: CA Cancer J Clin doi: 10.3322/caac.21551 – volume: 23 year: 2012 ident: B35 article-title: The risk of a second primary lung cancer after a first invasive breast cancer according to estrogen receptor status publication-title: Cancer Causes Control doi: 10.1007/s10552-012-0054-3 – volume: 33 year: 2014 ident: B36 article-title: Geriatric syndromes increased the nutritional risk in elderly cancer patients independently from tumoursite and metastatic status. The ELCAPA-05 cohort study publication-title: Clin Nutr doi: 10.1016/j.clnu.2013.05.014 – volume: 12 year: 2017 ident: B41 article-title: Prognostic significance of marital status in breast cancer survival: A population-based study publication-title: PloS One doi: 10.1371/journal.pone.0175515 – year: 2017 ident: B2 article-title: Global Burden of Disease Study 2017 Results publication-title: Glob Burd Dis Collab Netw |
| SSID | ssj0000650103 |
| Score | 2.252389 |
| Snippet | To estimate the risk of death from lung cancer in patients treated for breast cancer (BC) in relation to the general population.
BC data, covering 2000 to... To estimate the risk of death from lung cancer in patients treated for breast cancer (BC) in relation to the general population.OBJECTIVETo estimate the risk... ObjectiveTo estimate the risk of death from lung cancer in patients treated for breast cancer (BC) in relation to the general population.MethodsBC data,... |
| SourceID | doaj pubmedcentral proquest pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | 602397 |
| SubjectTerms | breast cancer chemotherapy general population lung cancer Oncology radiotherapy risk |
| Title | Lung Cancer Attributed Mortality Among 316,336 Early Stage Breast Cancer Cases Treated by Radiotherapy and/or Chemotherapy, 2000–2015: Evidence From the SEER Database |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/33718108 https://www.proquest.com/docview/2501477726 https://pubmed.ncbi.nlm.nih.gov/PMC7947230 https://doaj.org/article/c942e77ca68741d8945d269644be0076 |
| Volume | 10 |
| WOSCitedRecordID | wos000627337900001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: Directory of Open Access Journals customDbUrl: eissn: 2234-943X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000650103 issn: 2234-943X databaseCode: DOA dateStart: 20110101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources (selected full-text only) customDbUrl: eissn: 2234-943X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000650103 issn: 2234-943X databaseCode: M~E dateStart: 20110101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9NAEF5BhRCXijcpUA0SF6Sa2Gt718stDYk4kAqVIuVm7cs0UmtXiYvUC-p_6J_gd_FLmPEjShCCCxcf1rPyyjM7843mxdhrLaThqfWB4qEOksyiHuQuCQRSJxpvmMlcM2xCHh1l87n6tDHqi3LC2vbA7Y8bWpVwL6XVIkPj5zKVpI4LhWbceAojkfZF1LPhTLU6OKUBBm1cEr0wNSyqkjoW8vCtoHpOuWWHmnb9f8KYv6dKbtie6X2224FGGLWHfcBu-fIhuzvrwuKP2I-PeGVhTAxcwqhuh1h5B7MGWyPOhhHNFII4EgdxLKDpagyIM796OKSs9LrfPEajtoITQpK431zBsXaLrkjrCnTphhUSnfrzfu0AqArn5_UNmvj0HfRDSmG6rM4BaeDzZHIM73WtyV4-Zl-mk5Pxh6AbwRDYRPA6ED4rCkQJ3sdOqSSKbKFdasJCOB8KV4jUpSo0RlqZWG49zwziEY2gzihfILR6wnbKqvTPGIRIokMVR5qjV-IjJU0sUZ14YSKR2mjAhj1Dctv1J6cxGWc5-inEwpxYmBML85aFA_ZmveOi7c3xF9pD4vGajrpqNwsoa3kna_m_ZG3AXvUSkuMtpNCKLn11uco5hWcleipI87SVmPWn4hjtfxRmAya3ZGnrLNtvysVp0-kblaVEH3Hvfxz-ObvHKR-HyvHTF2ynXl76l-yO_VYvVst9dlvOs_3mEuFz9n3yC-BqH5o |
| linkProvider | Directory of Open Access Journals |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Lung+Cancer+Attributed+Mortality+Among+316%2C336+Early+Stage+Breast+Cancer+Cases+Treated+by+Radiotherapy+and%2For+Chemotherapy%2C+2000-2015%3A+Evidence+From+the+SEER+Database&rft.jtitle=Frontiers+in+oncology&rft.au=Abera%2C+Semaw+Ferede&rft.au=Mikolajczyk%2C+Rafael+T&rft.au=Kantelhardt%2C+Eva+Johanna&rft.au=Efremov%2C+Ljupcho&rft.date=2021-02-25&rft.issn=2234-943X&rft.eissn=2234-943X&rft.volume=10&rft.spage=602397&rft_id=info:doi/10.3389%2Ffonc.2020.602397&rft_id=info%3Apmid%2F33718108&rft.externalDocID=33718108 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2234-943X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2234-943X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2234-943X&client=summon |